nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—multiple sclerosis	0.194	1	CbGaD
Levothyroxine—SLCO4C1—Methotrexate—multiple sclerosis	0.0913	0.164	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—multiple sclerosis	0.0641	0.115	CbGbCtD
Levothyroxine—SLCO1A2—Prednisolone—multiple sclerosis	0.0466	0.0838	CbGbCtD
Levothyroxine—SLCO1A2—Prednisone—multiple sclerosis	0.044	0.0792	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—multiple sclerosis	0.0358	0.0643	CbGbCtD
Levothyroxine—SLCO1A2—Dexamethasone—multiple sclerosis	0.0275	0.0494	CbGbCtD
Levothyroxine—ALB—Prednisone—multiple sclerosis	0.0227	0.0409	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—multiple sclerosis	0.0221	0.0397	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—multiple sclerosis	0.0208	0.0375	CbGbCtD
Levothyroxine—ABCB1—Methylprednisolone—multiple sclerosis	0.0196	0.0353	CbGbCtD
Levothyroxine—CYP3A4—Fingolimod—multiple sclerosis	0.0183	0.0328	CbGbCtD
Levothyroxine—ABCB1—Mitoxantrone—multiple sclerosis	0.0143	0.0258	CbGbCtD
Levothyroxine—ABCB1—Betamethasone—multiple sclerosis	0.0128	0.023	CbGbCtD
Levothyroxine—ABCB1—Prednisolone—multiple sclerosis	0.0126	0.0227	CbGbCtD
Levothyroxine—ABCB1—Prednisone—multiple sclerosis	0.0119	0.0214	CbGbCtD
Levothyroxine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0118	0.0212	CbGbCtD
Levothyroxine—ALB—Methotrexate—multiple sclerosis	0.0114	0.0205	CbGbCtD
Levothyroxine—CYP2C8—Dexamethasone—multiple sclerosis	0.011	0.0197	CbGbCtD
Levothyroxine—CYP3A4—Triamcinolone—multiple sclerosis	0.00892	0.016	CbGbCtD
Levothyroxine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00858	0.0154	CbGbCtD
Levothyroxine—CYP3A4—Betamethasone—multiple sclerosis	0.00765	0.0138	CbGbCtD
Levothyroxine—CYP3A4—Prednisolone—multiple sclerosis	0.00755	0.0136	CbGbCtD
Levothyroxine—ABCB1—Dexamethasone—multiple sclerosis	0.00743	0.0134	CbGbCtD
Levothyroxine—CYP3A4—Prednisone—multiple sclerosis	0.00713	0.0128	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—multiple sclerosis	0.00597	0.0107	CbGbCtD
Levothyroxine—TTR—pineal body—multiple sclerosis	0.0045	0.0698	CbGeAlD
Levothyroxine—CYP3A4—Dexamethasone—multiple sclerosis	0.00445	0.008	CbGbCtD
Levothyroxine—TTR—peripheral nervous system—multiple sclerosis	0.00419	0.065	CbGeAlD
Levothyroxine—SERPINA7—spinal cord—multiple sclerosis	0.0019	0.0295	CbGeAlD
Levothyroxine—THRA—brainstem—multiple sclerosis	0.00189	0.0293	CbGeAlD
Levothyroxine—THRB—brainstem—multiple sclerosis	0.00189	0.0293	CbGeAlD
Levothyroxine—SERPINA7—nervous system—multiple sclerosis	0.0016	0.0248	CbGeAlD
Levothyroxine—SERPINA7—central nervous system—multiple sclerosis	0.00154	0.0239	CbGeAlD
Levothyroxine—SERPINA7—cerebellum—multiple sclerosis	0.00151	0.0234	CbGeAlD
Levothyroxine—TTR—brainstem—multiple sclerosis	0.0014	0.0218	CbGeAlD
Levothyroxine—SLC7A5—retina—multiple sclerosis	0.00139	0.0216	CbGeAlD
Levothyroxine—TTR—retina—multiple sclerosis	0.00135	0.021	CbGeAlD
Levothyroxine—SLCO4A1—retina—multiple sclerosis	0.00121	0.0188	CbGeAlD
Levothyroxine—SLC16A2—medulla oblongata—multiple sclerosis	0.00119	0.0185	CbGeAlD
Levothyroxine—THRA—spinal cord—multiple sclerosis	0.00117	0.0182	CbGeAlD
Levothyroxine—SLC16A2—spinal cord—multiple sclerosis	0.00106	0.0165	CbGeAlD
Levothyroxine—SLC7A5—medulla oblongata—multiple sclerosis	0.001	0.0156	CbGeAlD
Levothyroxine—SLCO1C1—midbrain—multiple sclerosis	0.001	0.0155	CbGeAlD
Levothyroxine—THRA—nervous system—multiple sclerosis	0.000988	0.0153	CbGeAlD
Levothyroxine—THRB—nervous system—multiple sclerosis	0.000988	0.0153	CbGeAlD
Levothyroxine—TTR—medulla oblongata—multiple sclerosis	0.000978	0.0152	CbGeAlD
Levothyroxine—SLCO1C1—spinal cord—multiple sclerosis	0.000975	0.0151	CbGeAlD
Levothyroxine—THRB—central nervous system—multiple sclerosis	0.000952	0.0148	CbGeAlD
Levothyroxine—THRA—central nervous system—multiple sclerosis	0.000952	0.0148	CbGeAlD
Levothyroxine—THRB—cerebellum—multiple sclerosis	0.00093	0.0144	CbGeAlD
Levothyroxine—THRA—cerebellum—multiple sclerosis	0.00093	0.0144	CbGeAlD
Levothyroxine—SLC7A5—midbrain—multiple sclerosis	0.000917	0.0142	CbGeAlD
Levothyroxine—SLC16A2—nervous system—multiple sclerosis	0.000896	0.0139	CbGeAlD
Levothyroxine—SLC7A5—spinal cord—multiple sclerosis	0.000895	0.0139	CbGeAlD
Levothyroxine—TTR—midbrain—multiple sclerosis	0.000894	0.0139	CbGeAlD
Levothyroxine—SLCO4A1—medulla oblongata—multiple sclerosis	0.000876	0.0136	CbGeAlD
Levothyroxine—TTR—spinal cord—multiple sclerosis	0.000872	0.0135	CbGeAlD
Levothyroxine—SLC16A2—central nervous system—multiple sclerosis	0.000862	0.0134	CbGeAlD
Levothyroxine—SLC16A2—cerebellum—multiple sclerosis	0.000843	0.0131	CbGeAlD
Levothyroxine—SLCO1C1—nervous system—multiple sclerosis	0.000822	0.0128	CbGeAlD
Levothyroxine—SLCO4A1—midbrain—multiple sclerosis	0.000801	0.0124	CbGeAlD
Levothyroxine—SLCO1C1—central nervous system—multiple sclerosis	0.000791	0.0123	CbGeAlD
Levothyroxine—SLCO4A1—spinal cord—multiple sclerosis	0.000782	0.0121	CbGeAlD
Levothyroxine—THRA—brain—multiple sclerosis	0.000756	0.0117	CbGeAlD
Levothyroxine—THRB—brain—multiple sclerosis	0.000756	0.0117	CbGeAlD
Levothyroxine—SLC7A5—nervous system—multiple sclerosis	0.000754	0.0117	CbGeAlD
Levothyroxine—TTR—nervous system—multiple sclerosis	0.000735	0.0114	CbGeAlD
Levothyroxine—SLC7A5—central nervous system—multiple sclerosis	0.000726	0.0113	CbGeAlD
Levothyroxine—SLC7A5—cerebellum—multiple sclerosis	0.00071	0.011	CbGeAlD
Levothyroxine—TTR—central nervous system—multiple sclerosis	0.000707	0.011	CbGeAlD
Levothyroxine—TTR—cerebellum—multiple sclerosis	0.000691	0.0107	CbGeAlD
Levothyroxine—SLC16A2—brain—multiple sclerosis	0.000684	0.0106	CbGeAlD
Levothyroxine—SLCO4A1—nervous system—multiple sclerosis	0.000659	0.0102	CbGeAlD
Levothyroxine—SLCO4A1—central nervous system—multiple sclerosis	0.000634	0.00984	CbGeAlD
Levothyroxine—SLCO1C1—brain—multiple sclerosis	0.000628	0.00975	CbGeAlD
Levothyroxine—SLCO1A2—medulla oblongata—multiple sclerosis	0.000628	0.00974	CbGeAlD
Levothyroxine—SLCO4A1—cerebellum—multiple sclerosis	0.00062	0.00962	CbGeAlD
Levothyroxine—SLC7A5—brain—multiple sclerosis	0.000576	0.00895	CbGeAlD
Levothyroxine—SLCO1A2—midbrain—multiple sclerosis	0.000574	0.0089	CbGeAlD
Levothyroxine—TTR—brain—multiple sclerosis	0.000562	0.00872	CbGeAlD
Levothyroxine—SLCO1A2—spinal cord—multiple sclerosis	0.00056	0.00869	CbGeAlD
Levothyroxine—SLC7A5—Desoximetasone—Methylprednisolone—multiple sclerosis	0.000531	0.174	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Dexamethasone—multiple sclerosis	0.000522	0.172	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Betamethasone—multiple sclerosis	0.000522	0.172	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Triamcinolone—multiple sclerosis	0.00051	0.168	CbGdCrCtD
Levothyroxine—SLCO4A1—brain—multiple sclerosis	0.000503	0.00781	CbGeAlD
Levothyroxine—SLC7A5—Desoximetasone—Prednisone—multiple sclerosis	0.000484	0.159	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Prednisolone—multiple sclerosis	0.000473	0.155	CbGdCrCtD
Levothyroxine—SLCO1A2—nervous system—multiple sclerosis	0.000472	0.00732	CbGeAlD
Levothyroxine—SLCO1A2—central nervous system—multiple sclerosis	0.000454	0.00705	CbGeAlD
Levothyroxine—SLCO1A2—cerebellum—multiple sclerosis	0.000444	0.00689	CbGeAlD
Levothyroxine—Affect lability—Betamethasone—multiple sclerosis	0.000373	0.0035	CcSEcCtD
Levothyroxine—Affect lability—Dexamethasone—multiple sclerosis	0.000373	0.0035	CcSEcCtD
Levothyroxine—Dyspnoea—Cladribine—multiple sclerosis	0.000369	0.00347	CcSEcCtD
Levothyroxine—Muscular weakness—Triamcinolone—multiple sclerosis	0.000368	0.00346	CcSEcCtD
Levothyroxine—Muscular weakness—Methylprednisolone—multiple sclerosis	0.000367	0.00345	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Prednisone—multiple sclerosis	0.000364	0.00342	CcSEcCtD
Levothyroxine—Irritability—Betamethasone—multiple sclerosis	0.000362	0.0034	CcSEcCtD
Levothyroxine—Irritability—Dexamethasone—multiple sclerosis	0.000362	0.0034	CcSEcCtD
Levothyroxine—SLCO1A2—brain—multiple sclerosis	0.00036	0.00559	CbGeAlD
Levothyroxine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00036	0.00339	CcSEcCtD
Levothyroxine—Cardiac arrest—Betamethasone—multiple sclerosis	0.00036	0.00339	CcSEcCtD
Levothyroxine—Mood swings—Betamethasone—multiple sclerosis	0.000359	0.00337	CcSEcCtD
Levothyroxine—Mood swings—Dexamethasone—multiple sclerosis	0.000359	0.00337	CcSEcCtD
Levothyroxine—ALB—brain—multiple sclerosis	0.000358	0.00556	CbGeAlD
Levothyroxine—Fatigue—Cladribine—multiple sclerosis	0.000357	0.00335	CcSEcCtD
Levothyroxine—Sweating increased—Triamcinolone—multiple sclerosis	0.000352	0.0033	CcSEcCtD
Levothyroxine—Increased appetite—Prednisone—multiple sclerosis	0.000351	0.0033	CcSEcCtD
Levothyroxine—Arthralgia—Azathioprine—multiple sclerosis	0.000351	0.0033	CcSEcCtD
Levothyroxine—Sweating increased—Methylprednisolone—multiple sclerosis	0.000351	0.0033	CcSEcCtD
Levothyroxine—Coma—Methotrexate—multiple sclerosis	0.000347	0.00326	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000345	0.00324	CcSEcCtD
Levothyroxine—Myocardial infarction—Prednisolone—multiple sclerosis	0.000343	0.00322	CcSEcCtD
Levothyroxine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000342	0.00321	CcSEcCtD
Levothyroxine—Feeling abnormal—Cladribine—multiple sclerosis	0.000341	0.0032	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000338	0.00318	CcSEcCtD
Levothyroxine—Alopecia—Mitoxantrone—multiple sclerosis	0.000338	0.00318	CcSEcCtD
Levothyroxine—Cardiac failure—Prednisone—multiple sclerosis	0.000338	0.00318	CcSEcCtD
Levothyroxine—Liotrix—ALB—multiple sclerosis	0.000337	0.578	CrCbGaD
Levothyroxine—Muscular weakness—Betamethasone—multiple sclerosis	0.000334	0.00314	CcSEcCtD
Levothyroxine—Muscular weakness—Dexamethasone—multiple sclerosis	0.000334	0.00314	CcSEcCtD
Levothyroxine—Urticaria—Cladribine—multiple sclerosis	0.000329	0.00309	CcSEcCtD
Levothyroxine—Body temperature increased—Cladribine—multiple sclerosis	0.000327	0.00307	CcSEcCtD
Levothyroxine—Abdominal pain—Cladribine—multiple sclerosis	0.000327	0.00307	CcSEcCtD
Levothyroxine—Affect lability—Prednisone—multiple sclerosis	0.000325	0.00305	CcSEcCtD
Levothyroxine—Sweating increased—Betamethasone—multiple sclerosis	0.000319	0.003	CcSEcCtD
Levothyroxine—Sweating increased—Dexamethasone—multiple sclerosis	0.000319	0.003	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000317	0.00298	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000317	0.00297	CcSEcCtD
Levothyroxine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000315	0.00296	CcSEcCtD
Levothyroxine—Irritability—Prednisone—multiple sclerosis	0.000315	0.00296	CcSEcCtD
Levothyroxine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000315	0.00296	CcSEcCtD
Levothyroxine—Cardiac arrest—Prednisone—multiple sclerosis	0.000314	0.00295	CcSEcCtD
Levothyroxine—Mood swings—Prednisone—multiple sclerosis	0.000313	0.00294	CcSEcCtD
Levothyroxine—Sweating—Methylprednisolone—multiple sclerosis	0.000308	0.00289	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000307	0.00288	CcSEcCtD
Levothyroxine—Asthenia—Cladribine—multiple sclerosis	0.000297	0.00279	CcSEcCtD
Levothyroxine—Weight decreased—Betamethasone—multiple sclerosis	0.000296	0.00278	CcSEcCtD
Levothyroxine—Weight decreased—Dexamethasone—multiple sclerosis	0.000296	0.00278	CcSEcCtD
Levothyroxine—Pruritus—Cladribine—multiple sclerosis	0.000293	0.00275	CcSEcCtD
Levothyroxine—Muscular weakness—Prednisone—multiple sclerosis	0.000291	0.00273	CcSEcCtD
Levothyroxine—ABCB1—retina—multiple sclerosis	0.000291	0.00452	CbGeAlD
Levothyroxine—Convulsion—Mitoxantrone—multiple sclerosis	0.000289	0.00271	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000288	0.0027	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000288	0.0027	CcSEcCtD
Levothyroxine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000286	0.00269	CcSEcCtD
Levothyroxine—Myocardial infarction—Betamethasone—multiple sclerosis	0.000286	0.00269	CcSEcCtD
Levothyroxine—Arthralgia—Mitoxantrone—multiple sclerosis	0.000284	0.00267	CcSEcCtD
Levothyroxine—Diarrhoea—Cladribine—multiple sclerosis	0.000283	0.00266	CcSEcCtD
Levothyroxine—Anxiety—Mitoxantrone—multiple sclerosis	0.000283	0.00266	CcSEcCtD
Levothyroxine—Arrhythmia—Prednisolone—multiple sclerosis	0.000281	0.00264	CcSEcCtD
Levothyroxine—Sweating increased—Prednisone—multiple sclerosis	0.000278	0.00261	CcSEcCtD
Levothyroxine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000277	0.00261	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000275	0.00259	CcSEcCtD
Levothyroxine—Confusional state—Mitoxantrone—multiple sclerosis	0.000274	0.00258	CcSEcCtD
Levothyroxine—Shock—Mitoxantrone—multiple sclerosis	0.000268	0.00252	CcSEcCtD
Levothyroxine—Abdominal pain—Azathioprine—multiple sclerosis	0.000266	0.0025	CcSEcCtD
Levothyroxine—Body temperature increased—Azathioprine—multiple sclerosis	0.000266	0.0025	CcSEcCtD
Levothyroxine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000265	0.0025	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—multiple sclerosis	0.000263	0.00247	CcSEcCtD
Levothyroxine—Vomiting—Cladribine—multiple sclerosis	0.000263	0.00247	CcSEcCtD
Levothyroxine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000263	0.00247	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—multiple sclerosis	0.000261	0.00245	CcSEcCtD
Levothyroxine—Rash—Cladribine—multiple sclerosis	0.000261	0.00245	CcSEcCtD
Levothyroxine—Dermatitis—Cladribine—multiple sclerosis	0.000261	0.00245	CcSEcCtD
Levothyroxine—Headache—Cladribine—multiple sclerosis	0.000259	0.00244	CcSEcCtD
Levothyroxine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000258	0.00243	CcSEcCtD
Levothyroxine—Weight decreased—Prednisone—multiple sclerosis	0.000258	0.00242	CcSEcCtD
Levothyroxine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000257	0.00242	CcSEcCtD
Levothyroxine—CYP2C8—brain—multiple sclerosis	0.000252	0.00391	CbGeAlD
Levothyroxine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000251	0.00236	CcSEcCtD
Levothyroxine—Angioedema—Prednisolone—multiple sclerosis	0.00025	0.00235	CcSEcCtD
Levothyroxine—Myocardial infarction—Prednisone—multiple sclerosis	0.000249	0.00234	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000248	0.00233	CcSEcCtD
Levothyroxine—Liothyronine—ALB—multiple sclerosis	0.000246	0.422	CrCbGaD
Levothyroxine—Nausea—Cladribine—multiple sclerosis	0.000246	0.00231	CcSEcCtD
Levothyroxine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000243	0.00228	CcSEcCtD
Levothyroxine—Convulsion—Prednisolone—multiple sclerosis	0.000237	0.00223	CcSEcCtD
Levothyroxine—Fatigue—Mitoxantrone—multiple sclerosis	0.000235	0.0022	CcSEcCtD
Levothyroxine—Arrhythmia—Betamethasone—multiple sclerosis	0.000234	0.0022	CcSEcCtD
Levothyroxine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000234	0.0022	CcSEcCtD
Levothyroxine—Alopecia—Dexamethasone—multiple sclerosis	0.000232	0.00218	CcSEcCtD
Levothyroxine—Alopecia—Betamethasone—multiple sclerosis	0.000232	0.00218	CcSEcCtD
Levothyroxine—Diarrhoea—Azathioprine—multiple sclerosis	0.00023	0.00216	CcSEcCtD
Levothyroxine—Angioedema—Triamcinolone—multiple sclerosis	0.00023	0.00216	CcSEcCtD
Levothyroxine—Angioedema—Methylprednisolone—multiple sclerosis	0.000229	0.00215	CcSEcCtD
Levothyroxine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000224	0.00211	CcSEcCtD
Levothyroxine—CYP3A4—nervous system—multiple sclerosis	0.000223	0.00346	CbGeAlD
Levothyroxine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000222	0.00209	CcSEcCtD
Levothyroxine—Shock—Prednisolone—multiple sclerosis	0.00022	0.00206	CcSEcCtD
Levothyroxine—Convulsion—Triamcinolone—multiple sclerosis	0.000218	0.00205	CcSEcCtD
Levothyroxine—Tachycardia—Prednisolone—multiple sclerosis	0.000218	0.00205	CcSEcCtD
Levothyroxine—Convulsion—Methylprednisolone—multiple sclerosis	0.000217	0.00204	CcSEcCtD
Levothyroxine—Urticaria—Mitoxantrone—multiple sclerosis	0.000216	0.00203	CcSEcCtD
Levothyroxine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000216	0.00203	CcSEcCtD
Levothyroxine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000215	0.00202	CcSEcCtD
Levothyroxine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000215	0.00202	CcSEcCtD
Levothyroxine—CYP3A4—central nervous system—multiple sclerosis	0.000215	0.00334	CbGeAlD
Levothyroxine—Vomiting—Azathioprine—multiple sclerosis	0.000214	0.00201	CcSEcCtD
Levothyroxine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000214	0.00201	CcSEcCtD
Levothyroxine—Anxiety—Methylprednisolone—multiple sclerosis	0.000213	0.002	CcSEcCtD
Levothyroxine—Rash—Azathioprine—multiple sclerosis	0.000212	0.00199	CcSEcCtD
Levothyroxine—Dermatitis—Azathioprine—multiple sclerosis	0.000212	0.00199	CcSEcCtD
Levothyroxine—Flushing—Prednisone—multiple sclerosis	0.000212	0.00199	CcSEcCtD
Levothyroxine—Headache—Azathioprine—multiple sclerosis	0.000211	0.00198	CcSEcCtD
Levothyroxine—ABCB1—medulla oblongata—multiple sclerosis	0.00021	0.00326	CbGeAlD
Levothyroxine—Angioedema—Betamethasone—multiple sclerosis	0.000208	0.00196	CcSEcCtD
Levothyroxine—Angioedema—Dexamethasone—multiple sclerosis	0.000208	0.00196	CcSEcCtD
Levothyroxine—Confusional state—Methylprednisolone—multiple sclerosis	0.000206	0.00194	CcSEcCtD
Levothyroxine—Arrhythmia—Prednisone—multiple sclerosis	0.000204	0.00192	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—multiple sclerosis	0.000204	0.00191	CcSEcCtD
Levothyroxine—Shock—Triamcinolone—multiple sclerosis	0.000202	0.0019	CcSEcCtD
Levothyroxine—Insomnia—Prednisolone—multiple sclerosis	0.000202	0.0019	CcSEcCtD
Levothyroxine—Alopecia—Prednisone—multiple sclerosis	0.000202	0.0019	CcSEcCtD
Levothyroxine—Shock—Methylprednisolone—multiple sclerosis	0.000201	0.00189	CcSEcCtD
Levothyroxine—Tachycardia—Triamcinolone—multiple sclerosis	0.0002	0.00188	CcSEcCtD
Levothyroxine—Nausea—Azathioprine—multiple sclerosis	0.0002	0.00188	CcSEcCtD
Levothyroxine—Tachycardia—Methylprednisolone—multiple sclerosis	0.0002	0.00188	CcSEcCtD
Levothyroxine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000198	0.00186	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000198	0.00186	CcSEcCtD
Levothyroxine—Convulsion—Betamethasone—multiple sclerosis	0.000198	0.00186	CcSEcCtD
Levothyroxine—Convulsion—Dexamethasone—multiple sclerosis	0.000198	0.00186	CcSEcCtD
Levothyroxine—Asthenia—Mitoxantrone—multiple sclerosis	0.000195	0.00183	CcSEcCtD
Levothyroxine—Anxiety—Dexamethasone—multiple sclerosis	0.000194	0.00182	CcSEcCtD
Levothyroxine—Anxiety—Betamethasone—multiple sclerosis	0.000194	0.00182	CcSEcCtD
Levothyroxine—ABCB1—midbrain—multiple sclerosis	0.000192	0.00298	CbGeAlD
Levothyroxine—ABCB1—spinal cord—multiple sclerosis	0.000187	0.00291	CbGeAlD
Levothyroxine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000187	0.00176	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000187	0.00175	CcSEcCtD
Levothyroxine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000186	0.00175	CcSEcCtD
Levothyroxine—Insomnia—Triamcinolone—multiple sclerosis	0.000186	0.00174	CcSEcCtD
Levothyroxine—Insomnia—Methylprednisolone—multiple sclerosis	0.000185	0.00174	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000184	0.00173	CcSEcCtD
Levothyroxine—Shock—Dexamethasone—multiple sclerosis	0.000183	0.00172	CcSEcCtD
Levothyroxine—Shock—Betamethasone—multiple sclerosis	0.000183	0.00172	CcSEcCtD
Levothyroxine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000183	0.00172	CcSEcCtD
Levothyroxine—Agitation—Prednisone—multiple sclerosis	0.000183	0.00172	CcSEcCtD
Levothyroxine—Tachycardia—Dexamethasone—multiple sclerosis	0.000182	0.00171	CcSEcCtD
Levothyroxine—Tachycardia—Betamethasone—multiple sclerosis	0.000182	0.00171	CcSEcCtD
Levothyroxine—Angioedema—Prednisone—multiple sclerosis	0.000182	0.00171	CcSEcCtD
Levothyroxine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00018	0.00169	CcSEcCtD
Levothyroxine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00018	0.00169	CcSEcCtD
Levothyroxine—Urticaria—Prednisolone—multiple sclerosis	0.000177	0.00167	CcSEcCtD
Levothyroxine—Fatigue—Triamcinolone—multiple sclerosis	0.000177	0.00166	CcSEcCtD
Levothyroxine—Fatigue—Methylprednisolone—multiple sclerosis	0.000177	0.00166	CcSEcCtD
Levothyroxine—Vomiting—Mitoxantrone—multiple sclerosis	0.000173	0.00163	CcSEcCtD
Levothyroxine—Convulsion—Prednisone—multiple sclerosis	0.000172	0.00162	CcSEcCtD
Levothyroxine—Rash—Mitoxantrone—multiple sclerosis	0.000172	0.00161	CcSEcCtD
Levothyroxine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000171	0.00161	CcSEcCtD
Levothyroxine—Headache—Mitoxantrone—multiple sclerosis	0.00017	0.0016	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00017	0.00159	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00017	0.00159	CcSEcCtD
Levothyroxine—Arthralgia—Prednisone—multiple sclerosis	0.000169	0.00159	CcSEcCtD
Levothyroxine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000169	0.00159	CcSEcCtD
Levothyroxine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000169	0.00159	CcSEcCtD
Levothyroxine—Anxiety—Prednisone—multiple sclerosis	0.000169	0.00158	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—multiple sclerosis	0.000169	0.00158	CcSEcCtD
Levothyroxine—Insomnia—Dexamethasone—multiple sclerosis	0.000168	0.00158	CcSEcCtD
Levothyroxine—Insomnia—Betamethasone—multiple sclerosis	0.000168	0.00158	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000167	0.00157	CcSEcCtD
Levothyroxine—Urticaria—Triamcinolone—multiple sclerosis	0.000163	0.00153	CcSEcCtD
Levothyroxine—Urticaria—Methylprednisolone—multiple sclerosis	0.000163	0.00153	CcSEcCtD
Levothyroxine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000162	0.00152	CcSEcCtD
Levothyroxine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000162	0.00152	CcSEcCtD
Levothyroxine—Nausea—Mitoxantrone—multiple sclerosis	0.000162	0.00152	CcSEcCtD
Levothyroxine—Fatigue—Betamethasone—multiple sclerosis	0.000161	0.00151	CcSEcCtD
Levothyroxine—Fatigue—Dexamethasone—multiple sclerosis	0.000161	0.00151	CcSEcCtD
Levothyroxine—Shock—Prednisone—multiple sclerosis	0.00016	0.0015	CcSEcCtD
Levothyroxine—Tachycardia—Prednisone—multiple sclerosis	0.000158	0.00149	CcSEcCtD
Levothyroxine—ABCB1—nervous system—multiple sclerosis	0.000158	0.00245	CbGeAlD
Levothyroxine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000157	0.00147	CcSEcCtD
Levothyroxine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000153	0.00144	CcSEcCtD
Levothyroxine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000153	0.00144	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000152	0.00143	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000152	0.00143	CcSEcCtD
Levothyroxine—ABCB1—central nervous system—multiple sclerosis	0.000152	0.00236	CbGeAlD
Levothyroxine—ABCB1—cerebellum—multiple sclerosis	0.000149	0.00231	CbGeAlD
Levothyroxine—Urticaria—Betamethasone—multiple sclerosis	0.000148	0.00139	CcSEcCtD
Levothyroxine—Urticaria—Dexamethasone—multiple sclerosis	0.000148	0.00139	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000148	0.00139	CcSEcCtD
Levothyroxine—Asthenia—Triamcinolone—multiple sclerosis	0.000147	0.00138	CcSEcCtD
Levothyroxine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000147	0.00138	CcSEcCtD
Levothyroxine—Body temperature increased—Betamethasone—multiple sclerosis	0.000147	0.00138	CcSEcCtD
Levothyroxine—Abdominal pain—Betamethasone—multiple sclerosis	0.000147	0.00138	CcSEcCtD
Levothyroxine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000147	0.00138	CcSEcCtD
Levothyroxine—Asthenia—Methylprednisolone—multiple sclerosis	0.000147	0.00138	CcSEcCtD
Levothyroxine—Insomnia—Prednisone—multiple sclerosis	0.000147	0.00138	CcSEcCtD
Levothyroxine—Pruritus—Triamcinolone—multiple sclerosis	0.000145	0.00136	CcSEcCtD
Levothyroxine—Pruritus—Methylprednisolone—multiple sclerosis	0.000145	0.00136	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—multiple sclerosis	0.000144	0.00135	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—multiple sclerosis	0.000141	0.00133	CcSEcCtD
Levothyroxine—Rash—Prednisolone—multiple sclerosis	0.000141	0.00132	CcSEcCtD
Levothyroxine—Dermatitis—Prednisolone—multiple sclerosis	0.000141	0.00132	CcSEcCtD
Levothyroxine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00014	0.00132	CcSEcCtD
Levothyroxine—Fatigue—Prednisone—multiple sclerosis	0.00014	0.00131	CcSEcCtD
Levothyroxine—Headache—Prednisolone—multiple sclerosis	0.00014	0.00131	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—multiple sclerosis	0.000137	0.00128	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisone—multiple sclerosis	0.000134	0.00126	CcSEcCtD
Levothyroxine—Asthenia—Dexamethasone—multiple sclerosis	0.000134	0.00126	CcSEcCtD
Levothyroxine—Asthenia—Betamethasone—multiple sclerosis	0.000134	0.00126	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000133	0.00125	CcSEcCtD
Levothyroxine—Nausea—Prednisolone—multiple sclerosis	0.000133	0.00125	CcSEcCtD
Levothyroxine—Pruritus—Betamethasone—multiple sclerosis	0.000132	0.00124	CcSEcCtD
Levothyroxine—Pruritus—Dexamethasone—multiple sclerosis	0.000132	0.00124	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000131	0.00123	CcSEcCtD
Levothyroxine—Vomiting—Triamcinolone—multiple sclerosis	0.00013	0.00123	CcSEcCtD
Levothyroxine—Vomiting—Methylprednisolone—multiple sclerosis	0.00013	0.00122	CcSEcCtD
Levothyroxine—Rash—Triamcinolone—multiple sclerosis	0.000129	0.00122	CcSEcCtD
Levothyroxine—Dermatitis—Triamcinolone—multiple sclerosis	0.000129	0.00121	CcSEcCtD
Levothyroxine—Rash—Methylprednisolone—multiple sclerosis	0.000129	0.00121	CcSEcCtD
Levothyroxine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000129	0.00121	CcSEcCtD
Levothyroxine—Urticaria—Prednisone—multiple sclerosis	0.000129	0.00121	CcSEcCtD
Levothyroxine—Headache—Triamcinolone—multiple sclerosis	0.000129	0.00121	CcSEcCtD
Levothyroxine—Headache—Methylprednisolone—multiple sclerosis	0.000128	0.00121	CcSEcCtD
Levothyroxine—Abdominal pain—Prednisone—multiple sclerosis	0.000128	0.0012	CcSEcCtD
Levothyroxine—Body temperature increased—Prednisone—multiple sclerosis	0.000128	0.0012	CcSEcCtD
Levothyroxine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000127	0.0012	CcSEcCtD
Levothyroxine—Diarrhoea—Betamethasone—multiple sclerosis	0.000127	0.0012	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000123	0.00116	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—multiple sclerosis	0.000123	0.00115	CcSEcCtD
Levothyroxine—Nausea—Triamcinolone—multiple sclerosis	0.000122	0.00115	CcSEcCtD
Levothyroxine—Nausea—Methylprednisolone—multiple sclerosis	0.000122	0.00114	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—multiple sclerosis	0.000121	0.00114	CcSEcCtD
Levothyroxine—ABCB1—brain—multiple sclerosis	0.000121	0.00187	CbGeAlD
Levothyroxine—Vomiting—Dexamethasone—multiple sclerosis	0.000118	0.00111	CcSEcCtD
Levothyroxine—Vomiting—Betamethasone—multiple sclerosis	0.000118	0.00111	CcSEcCtD
Levothyroxine—Rash—Dexamethasone—multiple sclerosis	0.000117	0.0011	CcSEcCtD
Levothyroxine—Rash—Betamethasone—multiple sclerosis	0.000117	0.0011	CcSEcCtD
Levothyroxine—Dermatitis—Dexamethasone—multiple sclerosis	0.000117	0.0011	CcSEcCtD
Levothyroxine—Dermatitis—Betamethasone—multiple sclerosis	0.000117	0.0011	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—multiple sclerosis	0.000117	0.0011	CcSEcCtD
Levothyroxine—Headache—Betamethasone—multiple sclerosis	0.000117	0.0011	CcSEcCtD
Levothyroxine—Headache—Dexamethasone—multiple sclerosis	0.000117	0.0011	CcSEcCtD
Levothyroxine—Asthenia—Prednisone—multiple sclerosis	0.000116	0.00109	CcSEcCtD
Levothyroxine—Pruritus—Prednisone—multiple sclerosis	0.000115	0.00108	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000112	0.00105	CcSEcCtD
Levothyroxine—Diarrhoea—Prednisone—multiple sclerosis	0.000111	0.00104	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000111	0.00104	CcSEcCtD
Levothyroxine—Nausea—Dexamethasone—multiple sclerosis	0.000111	0.00104	CcSEcCtD
Levothyroxine—Nausea—Betamethasone—multiple sclerosis	0.000111	0.00104	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—multiple sclerosis	0.000108	0.00101	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—multiple sclerosis	0.000107	0.00101	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—multiple sclerosis	0.000107	0.00101	CcSEcCtD
Levothyroxine—Vomiting—Prednisone—multiple sclerosis	0.000103	0.000969	CcSEcCtD
Levothyroxine—Rash—Prednisone—multiple sclerosis	0.000102	0.000961	CcSEcCtD
Levothyroxine—Dermatitis—Prednisone—multiple sclerosis	0.000102	0.00096	CcSEcCtD
Levothyroxine—Headache—Prednisone—multiple sclerosis	0.000102	0.000955	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—multiple sclerosis	9.72e-05	0.000914	CcSEcCtD
Levothyroxine—Nausea—Prednisone—multiple sclerosis	9.63e-05	0.000905	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—multiple sclerosis	9.59e-05	0.000901	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—multiple sclerosis	9.27e-05	0.000871	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—multiple sclerosis	8.62e-05	0.00081	CcSEcCtD
Levothyroxine—Rash—Methotrexate—multiple sclerosis	8.55e-05	0.000803	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—multiple sclerosis	8.54e-05	0.000802	CcSEcCtD
Levothyroxine—Headache—Methotrexate—multiple sclerosis	8.49e-05	0.000798	CcSEcCtD
Levothyroxine—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	8.41e-05	0.00112	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TAGAP—multiple sclerosis	8.37e-05	0.00111	CbGpPWpGaD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.35e-05	0.00111	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—SRM—multiple sclerosis	8.18e-05	0.00109	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.07e-05	0.00107	CbGpPWpGaD
Levothyroxine—Nausea—Methotrexate—multiple sclerosis	8.05e-05	0.000757	CcSEcCtD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.93e-05	0.00105	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.9e-05	0.00105	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.88e-05	0.00105	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—PGR—multiple sclerosis	7.86e-05	0.00104	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—PGR—multiple sclerosis	7.86e-05	0.00104	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—IL2RA—multiple sclerosis	7.77e-05	0.00103	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	7.61e-05	0.00101	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.57e-05	0.00101	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	7.53e-05	0.001	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—S1PR1—multiple sclerosis	7.31e-05	0.000972	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MERTK—multiple sclerosis	7.2e-05	0.000956	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CD58—multiple sclerosis	7.2e-05	0.000956	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SELPLG—multiple sclerosis	7.2e-05	0.000956	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	7.11e-05	0.000946	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—GPC5—multiple sclerosis	7.11e-05	0.000946	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.01e-05	0.000931	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.98e-05	0.000928	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.98e-05	0.000928	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.88e-05	0.000915	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.88e-05	0.000915	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	6.85e-05	0.000911	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—ICAM1—multiple sclerosis	6.84e-05	0.000909	CbGpPWpGaD
Levothyroxine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.79e-05	0.000903	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.74e-05	0.000895	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	6.72e-05	0.000893	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	6.72e-05	0.000893	CbGpPWpGaD
Levothyroxine—TTR—Disease—RPL5—multiple sclerosis	6.61e-05	0.000878	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	6.54e-05	0.000869	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SRM—multiple sclerosis	6.42e-05	0.000854	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	6.4e-05	0.000851	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.39e-05	0.000849	CbGpPWpGaD
Levothyroxine—TTR—Disease—SLC11A1—multiple sclerosis	6.33e-05	0.000841	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.23e-05	0.000828	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RGS1—multiple sclerosis	6.22e-05	0.000826	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—CCL2—multiple sclerosis	6.12e-05	0.000814	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—MMP9—multiple sclerosis	6.08e-05	0.000808	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	6.02e-05	0.000801	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.99e-05	0.000796	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.92e-05	0.000787	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—GPR65—multiple sclerosis	5.89e-05	0.000784	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	5.76e-05	0.000766	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	5.76e-05	0.000766	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	5.71e-05	0.000759	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.63e-05	0.000748	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—ALB—multiple sclerosis	5.62e-05	0.000746	CbGpPWpGaD
Levothyroxine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.51e-05	0.000732	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.5e-05	0.000732	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—VDR—multiple sclerosis	5.49e-05	0.00073	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—VDR—multiple sclerosis	5.49e-05	0.00073	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SRM—multiple sclerosis	5.49e-05	0.00073	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	5.44e-05	0.000723	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.41e-05	0.000719	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCR1—multiple sclerosis	5.39e-05	0.000717	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL13—multiple sclerosis	5.39e-05	0.000717	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.32e-05	0.000708	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.31e-05	0.000706	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.31e-05	0.000706	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.29e-05	0.000703	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GPC5—multiple sclerosis	5.27e-05	0.0007	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IFNG—multiple sclerosis	5.21e-05	0.000692	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.08e-05	0.000675	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD28—multiple sclerosis	5.05e-05	0.000672	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—TGFB1—multiple sclerosis	5.01e-05	0.000666	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5e-05	0.000664	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.99e-05	0.000664	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.99e-05	0.000664	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.97e-05	0.00066	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.97e-05	0.00066	CbGpPWpGaD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.96e-05	0.00066	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.86e-05	0.000647	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.86e-05	0.000646	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.71e-05	0.000626	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL1B—multiple sclerosis	4.64e-05	0.000617	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL2—multiple sclerosis	4.63e-05	0.000615	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—IL2—multiple sclerosis	4.55e-05	0.000605	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—MYC—multiple sclerosis	4.53e-05	0.000603	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—MYC—multiple sclerosis	4.53e-05	0.000603	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	4.53e-05	0.000602	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	4.53e-05	0.000602	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.45e-05	0.000592	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.45e-05	0.000591	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PLEK—multiple sclerosis	4.45e-05	0.000591	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.42e-05	0.000588	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—RRM1—multiple sclerosis	4.37e-05	0.00058	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.33e-05	0.000575	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	4.14e-05	0.000551	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GPC5—multiple sclerosis	4.14e-05	0.00055	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	4.14e-05	0.00055	CbGpPWpGaD
Levothyroxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.02e-05	0.000535	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.95e-05	0.000525	CbGpPWpGaD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.9e-05	0.000518	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	3.87e-05	0.000514	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	3.87e-05	0.000514	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.85e-05	0.000512	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL3—multiple sclerosis	3.84e-05	0.000511	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.78e-05	0.000503	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTGER4—multiple sclerosis	3.7e-05	0.000492	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.69e-05	0.00049	CbGpPWpGaD
Levothyroxine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.65e-05	0.000485	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PGR—multiple sclerosis	3.64e-05	0.000484	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD86—multiple sclerosis	3.6e-05	0.000479	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCR3—multiple sclerosis	3.57e-05	0.000475	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TGFB1—multiple sclerosis	3.55e-05	0.000472	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GPC5—multiple sclerosis	3.54e-05	0.00047	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CD28—multiple sclerosis	3.54e-05	0.00047	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.52e-05	0.000468	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.51e-05	0.000467	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—MAPK1—multiple sclerosis	3.48e-05	0.000463	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCR2—multiple sclerosis	3.47e-05	0.000462	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.47e-05	0.000462	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—RRM1—multiple sclerosis	3.43e-05	0.000456	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.39e-05	0.00045	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.37e-05	0.000448	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TNF—multiple sclerosis	3.37e-05	0.000448	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	3.34e-05	0.000444	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.33e-05	0.000443	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CNR1—multiple sclerosis	3.21e-05	0.000426	CbGpPWpGaD
Levothyroxine—TTR—Disease—CCR5—multiple sclerosis	3.2e-05	0.000425	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SRM—multiple sclerosis	3.16e-05	0.00042	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SRM—multiple sclerosis	3.14e-05	0.000417	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SELE—multiple sclerosis	3.13e-05	0.000416	CbGpPWpGaD
Levothyroxine—TTR—Disease—HLA-A—multiple sclerosis	3.12e-05	0.000414	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—TGFB1—multiple sclerosis	3.09e-05	0.000411	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.04e-05	0.000404	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	3e-05	0.000399	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.97e-05	0.000395	CbGpPWpGaD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.96e-05	0.000393	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.95e-05	0.000392	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.93e-05	0.00039	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.93e-05	0.000389	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.91e-05	0.000387	CbGpPWpGaD
Levothyroxine—TTR—Disease—APOE—multiple sclerosis	2.91e-05	0.000387	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL10—multiple sclerosis	2.89e-05	0.000384	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SRM—multiple sclerosis	2.75e-05	0.000365	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.74e-05	0.000364	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL6—multiple sclerosis	2.72e-05	0.000361	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.69e-05	0.000357	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.68e-05	0.000356	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.67e-05	0.000354	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.66e-05	0.000354	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.65e-05	0.000353	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD80—multiple sclerosis	2.63e-05	0.00035	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.56e-05	0.00034	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CD86—multiple sclerosis	2.52e-05	0.000336	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.52e-05	0.000335	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—BCHE—multiple sclerosis	2.51e-05	0.000333	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL5—multiple sclerosis	2.49e-05	0.00033	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.36e-05	0.000313	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SPP1—multiple sclerosis	2.3e-05	0.000306	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.29e-05	0.000304	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.28e-05	0.000302	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—ITGA4—multiple sclerosis	2.26e-05	0.000301	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IFNB1—multiple sclerosis	2.25e-05	0.000299	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCR5—multiple sclerosis	2.24e-05	0.000298	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.22e-05	0.000296	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.22e-05	0.000296	CbGpPWpGaD
Levothyroxine—TTR—Disease—TYK2—multiple sclerosis	2.22e-05	0.000295	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP27B1—multiple sclerosis	2.21e-05	0.000294	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP24A1—multiple sclerosis	2.21e-05	0.000294	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2RA—multiple sclerosis	2.21e-05	0.000293	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MYC—multiple sclerosis	2.18e-05	0.00029	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—MYC—multiple sclerosis	2.18e-05	0.00029	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.17e-05	0.000289	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.16e-05	0.000287	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.16e-05	0.000287	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.08e-05	0.000277	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—APOE—multiple sclerosis	2.04e-05	0.000271	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.03e-05	0.00027	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GPC5—multiple sclerosis	2.02e-05	0.000269	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD4—multiple sclerosis	2.01e-05	0.000267	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.98e-05	0.000263	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.97e-05	0.000262	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.95e-05	0.00026	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.94e-05	0.000258	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.94e-05	0.000258	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CD80—multiple sclerosis	1.84e-05	0.000245	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.78e-05	0.000237	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.77e-05	0.000236	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.76e-05	0.000234	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—POMC—multiple sclerosis	1.75e-05	0.000233	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL2—multiple sclerosis	1.71e-05	0.000228	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.69e-05	0.000225	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.69e-05	0.000225	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.69e-05	0.000224	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.68e-05	0.000224	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—RRM1—multiple sclerosis	1.68e-05	0.000223	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.57e-05	0.000209	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TYK2—multiple sclerosis	1.55e-05	0.000207	CbGpPWpGaD
Levothyroxine—TTR—Disease—STAT3—multiple sclerosis	1.55e-05	0.000207	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2RA—multiple sclerosis	1.55e-05	0.000206	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—APOE—multiple sclerosis	1.51e-05	0.0002	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.47e-05	0.000195	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—multiple sclerosis	1.44e-05	0.000192	CbGpPWpGaD
Levothyroxine—TTR—Disease—TGFB1—multiple sclerosis	1.44e-05	0.000192	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK1—multiple sclerosis	1.41e-05	0.000188	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.37e-05	0.000182	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.35e-05	0.00018	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.35e-05	0.00018	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.35e-05	0.000179	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.33e-05	0.000176	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.31e-05	0.000174	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.3e-05	0.000173	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000172	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—multiple sclerosis	1.29e-05	0.000172	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.26e-05	0.000168	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—multiple sclerosis	1.22e-05	0.000163	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.19e-05	0.000159	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.19e-05	0.000159	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.19e-05	0.000158	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—multiple sclerosis	1.18e-05	0.000157	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000149	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000148	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.09e-05	0.000145	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—multiple sclerosis	1.09e-05	0.000145	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—multiple sclerosis	1.09e-05	0.000144	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	0.000136	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—POMC—multiple sclerosis	1.02e-05	0.000135	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.01e-05	0.000135	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—multiple sclerosis	1.01e-05	0.000134	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—multiple sclerosis	1.01e-05	0.000134	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK1—multiple sclerosis	9.9e-06	0.000132	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—BCHE—multiple sclerosis	9.68e-06	0.000129	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—BCHE—multiple sclerosis	9.62e-06	0.000128	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—multiple sclerosis	9.28e-06	0.000123	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—multiple sclerosis	9.07e-06	0.000121	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.05e-06	0.00012	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—POMC—multiple sclerosis	8.71e-06	0.000116	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.48e-06	0.000113	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—BCHE—multiple sclerosis	8.43e-06	0.000112	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—multiple sclerosis	7.94e-06	0.000105	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—multiple sclerosis	7.6e-06	0.000101	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—multiple sclerosis	7.07e-06	9.4e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK1—multiple sclerosis	6.94e-06	9.22e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOE—multiple sclerosis	5.82e-06	7.74e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOE—multiple sclerosis	5.79e-06	7.7e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.2e-06	6.91e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOE—multiple sclerosis	5.07e-06	6.74e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—POMC—multiple sclerosis	5e-06	6.65e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—POMC—multiple sclerosis	4.97e-06	6.61e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—multiple sclerosis	4.56e-06	6.06e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—POMC—multiple sclerosis	4.36e-06	5.79e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—multiple sclerosis	3.97e-06	5.28e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.13e-06	4.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.69e-06	3.57e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.45e-06	3.25e-05	CbGpPWpGaD
